Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Asmus

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|March 11, 2000
Levalbuterol nebulizer solution: is it worth five times the cost of albuterol?M J Asmus, L Hendeles
Chest|August 24, 1999
Low- vs high-dose inhaled albuterol for the treatment of acute asthmaM J Asmus, L Hendeles
The Journal of Allergy and Clinical Immunology|August 19, 1999
Bronchoconstrictor additives in bronchodilator solutionsM J Asmus, J Sherman, L Hendeles
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|May 25, 2001
Multicenter survey of pharmacy faculty and student metered-dose inhaler knowledgeM J Asmus, G Milavetz, M E Teresi
American Journal of Respiratory and Critical Care Medicine|December 6, 2001
Therapeutic ratio of inhaled corticosteroids: fact or fiction?M J Asmus, L Hendeles, R C Ahrens, et al.
Pharmacotherapy|May 15, 2001
In vitro characteristics of tobramycin aerosol from ultrasonic and jet nebulizersM J Asmus, G Milavetz, A L Tice, et al.
Pharmacotherapy|February 20, 1998
Evaluation of a noninstrumented disposable method for quantifying serum theophylline concentrationsM J Asmus, G Milavetz, M E Teresi, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2001
Pulmonary function response to EDTA, an additive in nebulized bronchodilatorsM J Asmus, M D Barros, J Liang, et al.
Clinical Pharmacology and Therapeutics|December 9, 1997
Apparent decrease in population clearance of theophylline: implications for dosageM J Asmus, M M Weinberger, G Milavetz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|March 11, 2000
Levalbuterol nebulizer solution: is it worth five times the cost of albuterol?M J Asmus, L Hendeles
Chest|August 24, 1999
Low- vs high-dose inhaled albuterol for the treatment of acute asthmaM J Asmus, L Hendeles
The Journal of Allergy and Clinical Immunology|August 19, 1999
Bronchoconstrictor additives in bronchodilator solutionsM J Asmus, J Sherman, L Hendeles
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|May 25, 2001
Multicenter survey of pharmacy faculty and student metered-dose inhaler knowledgeM J Asmus, G Milavetz, M E Teresi
American Journal of Respiratory and Critical Care Medicine|December 6, 2001
Therapeutic ratio of inhaled corticosteroids: fact or fiction?M J Asmus, L Hendeles, R C Ahrens, et al.
Pharmacotherapy|May 15, 2001
In vitro characteristics of tobramycin aerosol from ultrasonic and jet nebulizersM J Asmus, G Milavetz, A L Tice, et al.
Pharmacotherapy|February 20, 1998
Evaluation of a noninstrumented disposable method for quantifying serum theophylline concentrationsM J Asmus, G Milavetz, M E Teresi, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2001
Pulmonary function response to EDTA, an additive in nebulized bronchodilatorsM J Asmus, M D Barros, J Liang, et al.
Clinical Pharmacology and Therapeutics|December 9, 1997
Apparent decrease in population clearance of theophylline: implications for dosageM J Asmus, M M Weinberger, G Milavetz, et al.
Pageof 1